Hanmi Science Co., Ltd. (008930) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hanmi Science Co., Ltd. (008930:KRX), powered by AI.

Current Price
₩30,350
P/E Ratio
17.4
Market Cap
2.1T
Sector
Healthcare
What is the Hanmi Science Co., Ltd. stock price forecast?

Hanmi Science Co., Ltd. is currently trading at ₩30,350. View real-time AI analysis on Alpha Lenz.

What is Hanmi Science Co., Ltd. insider trading activity?

View the latest insider trading data for Hanmi Science Co., Ltd. on Alpha Lenz.

What is Hanmi Science Co., Ltd.'s P/E ratio?

Hanmi Science Co., Ltd.'s P/E ratio is 17.4.

Hanmi Science Co., Ltd.

KRX · 008930
₩30,350+250(+0.83%)Market closedKRX regular session 09:00–15:30 KST
Ask about Hanmi Science Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Hanmi Science Co., Ltd. trades at a P/E of 17.4 (fair value) with solid ROE of 13.1%.

Ask for details

Company Overview

Hanmi Science Co., Ltd. is a prominent South Korean company engaged in the pharmaceutical and biotechnology sectors, with a focus on developing innovative healthcare solutions. As the holding company of Hanmi Pharmaceuticals, its primary function is to drive drug discovery and ensure the availability of effective medical products. Hanmi Science undertakes research and development activities, emphasizing biopharmaceuticals and chemical drugs, particularly in areas like oncology, diabetes, and autoimmune diseases. The company plays a vital role in the healthcare industry by advancing medical research and contributing to improving public health outcomes. Operating as a key player within the biotechnology market, Hanmi Science influences the proliferation of cutting-edge therapies and medicines, both in South Korea and internationally. Its commitment to innovation and therapeutic advancements has positioned it as a critical contributor to the global pharmaceuticals landscape, impacting not only direct healthcare provision but also broader industry research collaborations and partnerships.

CEO김재교
SectorHealthcare
IndustryMedical Distribution
Employees443

Company Statistics

FY 2025

Profile

₩2,058,585,655,000Market Cap
₩1,356,957,532,840Revenue
68.39MShares Out
443Employees

Margins

23.25%Gross
11.22%EBITDA
4.20%Operating
9.80%Pre-Tax
8.67%Net

Valuation

17.39P/E
2.14P/B
1.52EV/Sales
14.08EV/EBITDA
76.97P/FCF

Growth (CAGR)

9.06%Rev 3Yr
9.62%Rev 5Yr
26.54%Op Inc 3Yr
17.76%Op Inc 5Yr
19.47%Net Inc 3Yr
39.11%Net Inc 5Yr

Returns

8.29%ROA
13.13%ROE
10.12%ROIC

Financial Health

₩127,389,343,690Cash & Cash Equivalents
₩402,464,681,830Net Debt
55.24%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Hanmi Science Co., Ltd. (ticker: 008930) is a company listed on KRX in the Healthcare sector (Medical Distribution). It has approximately 443 employees. Market cap is $2.1T.

The current price is ₩30,350 with a P/E ratio of 17.39x and P/B of 2.14x.

ROE is 13.13% and operating margin is 4.20%. Annual revenue is $1.4T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Hanmi Science Co., Ltd. (008930) Stock Forecast 2026 ₩30,350 — Price, Financials & Analyst Targets | Alpha Lenz